Figure 5.
PAFR-modulated TAM phenotype. In a (B16F10) and b (TC-1), we show a representative analysis of the macrophage populations (CD45+CD11b+ F4/80+) expressing the M1-like marker, CD11c, or the M2-like marker, CD206, from WT and PAFR KO tumors. ∗ indicates p < 0.05 for WT compared with PAFR KO tumors. Each experimental group contained 4 animals.